Home » Topics » Regulatory

Regulatory
RSS

FDA approves Zinbryta as once-monthly treatment for relapsing MS

May 30, 2016

FDA approves Fanapt sNDA for maintenance treatment of schizophrenia in adults

May 27, 2016

FDA approves Probuphine for opioid dependence

May 27, 2016

CSL gains FDA approval for lonoctocog alpha

May 27, 2016

FDA approves Janssen Pharmaceutical's Invokamet line extension

May 25, 2016

FDA approves Flucelvax Quadrivalent

May 25, 2016

Avastin approved in Japan for cervical cancer

May 24, 2016

FDA approves Tecentriq and complementary diagnostic for metastatic urothelial carcinoma

May 19, 2016

Boehringer Ingelheim's olmunitib receives approval in South Korea

May 18, 2016

FDA grants accelerated approval to nivolumab for patients with classical Hodgkin's lymphoma

May 18, 2016

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....